Patricia L. Morris

Array ( [id] => 5035391 [patent_doc_number] => 20070099930 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Substituted Dihydroisoindolones As Allosteric Modulators of Glucokinase' [patent_app_type] => utility [patent_app_number] => 11/554500 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31729 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20070099930.pdf [firstpage_image] =>[orig_patent_app_number] => 11554500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4599868 [patent_doc_number] => 07977359 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-07-12 [patent_title] => '5-lipdxygenase-activating protein (FLAP) inhibitors' [patent_app_type] => utility [patent_app_number] => 11/553946 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 65211 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/977/07977359.pdf [firstpage_image] =>[orig_patent_app_number] => 11553946 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860431 [patent_doc_number] => 20080269281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Novel Beta-Agonists, Method for Producing Them and Their Use as Drugs' [patent_app_type] => utility [patent_app_number] => 12/091828 [patent_app_country] => US [patent_app_date] => 2006-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9282 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269281.pdf [firstpage_image] =>[orig_patent_app_number] => 12091828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664277 [patent_doc_number] => 20080255184 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Thienopyridine B-Raf Kinase Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/090575 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13263 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255184.pdf [firstpage_image] =>[orig_patent_app_number] => 12090575 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9441121 [patent_doc_number] => 08710232 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-29 [patent_title] => 'Imidazole derivatives used as TAFIa inhibitors' [patent_app_type] => utility [patent_app_number] => 11/551975 [patent_app_country] => US [patent_app_date] => 2006-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25381 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11551975 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5107784 [patent_doc_number] => 20070066662 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-22 [patent_title] => 'PROCESS FOR THE PREPARATION OF THIAZOLIDINEDIONE DERIVATIVES' [patent_app_type] => utility [patent_app_number] => 11/550506 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1444 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20070066662.pdf [firstpage_image] =>[orig_patent_app_number] => 11550506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5417057 [patent_doc_number] => 20090042944 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-12 [patent_title] => 'Potassium Channel Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/992919 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9614 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0042/20090042944.pdf [firstpage_image] =>[orig_patent_app_number] => 11992919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5343499 [patent_doc_number] => 20090182149 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-16 [patent_title] => 'SALT OF SULFINYLBENZIMIDAZOLE COMPOUND, AND CRYSTAL AND AMORPHOUS FORM THEREOF' [patent_app_type] => utility [patent_app_number] => 12/296902 [patent_app_country] => US [patent_app_date] => 2006-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 22235 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20090182149.pdf [firstpage_image] =>[orig_patent_app_number] => 12296902 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8725734 [patent_doc_number] => 08404853 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-26 [patent_title] => 'Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds' [patent_app_type] => utility [patent_app_number] => 12/307399 [patent_app_country] => US [patent_app_date] => 2006-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4401 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12307399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5194445 [patent_doc_number] => 20070082929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-12 [patent_title] => 'Inhibitors of the gastric H+, K+-atpase with enhanced therapeutic properties' [patent_app_type] => utility [patent_app_number] => 11/544407 [patent_app_country] => US [patent_app_date] => 2006-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29875 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 20 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20070082929.pdf [firstpage_image] =>[orig_patent_app_number] => 11544407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5205633 [patent_doc_number] => 20070027115 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-01 [patent_title] => 'Triazole derivatives useful in therapy' [patent_app_type] => utility [patent_app_number] => 11/540375 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7967 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20070027115.pdf [firstpage_image] =>[orig_patent_app_number] => 11540375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4664279 [patent_doc_number] => 20080255186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-16 [patent_title] => 'Pyrazolo[3,4-B]Pyridine Compound, and Its Use as a Pde4 Inhibitor' [patent_app_type] => utility [patent_app_number] => 12/067994 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34797 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0255/20080255186.pdf [firstpage_image] =>[orig_patent_app_number] => 12067994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5172400 [patent_doc_number] => 20070072833 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-29 [patent_title] => 'Survivin inhibitors' [patent_app_type] => utility [patent_app_number] => 11/529845 [patent_app_country] => US [patent_app_date] => 2006-09-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32594 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20070072833.pdf [firstpage_image] =>[orig_patent_app_number] => 11529845 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 865206 [patent_doc_number] => 07368574 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-06 [patent_title] => 'Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use' [patent_app_type] => utility [patent_app_number] => 11/536313 [patent_app_country] => US [patent_app_date] => 2006-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3019 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/368/07368574.pdf [firstpage_image] =>[orig_patent_app_number] => 11536313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8164768 [patent_doc_number] => 08173682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-05-08 [patent_title] => 'Substituted pyridones as inhibitors of poly(ADP-ribose) polymerase (PARP)' [patent_app_type] => utility [patent_app_number] => 11/535127 [patent_app_country] => US [patent_app_date] => 2006-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 78703 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/173/08173682.pdf [firstpage_image] =>[orig_patent_app_number] => 11535127 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1077050 [patent_doc_number] => 07615565 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-10 [patent_title] => 'VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines' [patent_app_type] => utility [patent_app_number] => 11/525091 [patent_app_country] => US [patent_app_date] => 2006-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11178 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/615/07615565.pdf [firstpage_image] =>[orig_patent_app_number] => 11525091 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4823394 [patent_doc_number] => 20080227824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-18 [patent_title] => '5-(Phenylisoxazolylethoxy) - Triazol- 3 -Yl Substituted Pyridine Compounds for the Treatment of Neurological, Psychiatric or Pain Disorders' [patent_app_type] => utility [patent_app_number] => 12/067270 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7643 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20080227824.pdf [firstpage_image] =>[orig_patent_app_number] => 12067270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 369911 [patent_doc_number] => 07476684 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-13 [patent_title] => 'Compounds for the treatment of neurological, psychiatric or pain disorders' [patent_app_type] => utility [patent_app_number] => 11/523717 [patent_app_country] => US [patent_app_date] => 2006-09-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7656 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/476/07476684.pdf [firstpage_image] =>[orig_patent_app_number] => 11523717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4995189 [patent_doc_number] => 20070010534 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-01-11 [patent_title] => 'NOVEL COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/533034 [patent_app_country] => US [patent_app_date] => 2006-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13454 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0010/20070010534.pdf [firstpage_image] =>[orig_patent_app_number] => 11533034 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 800488 [patent_doc_number] => 07425634 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-16 [patent_title] => 'Benzimidazole compound' [patent_app_type] => utility [patent_app_number] => 11/520838 [patent_app_country] => US [patent_app_date] => 2006-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 77203 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/425/07425634.pdf [firstpage_image] =>[orig_patent_app_number] => 11520838 [rel_patent_id] =>[rel_patent_doc_number] =>)